| Ytd | 1.46% | |
| 1y | -34.12% |
| Open | 33.45 | Prev Close | 32.73 | Low | 32.57 | High | 34.00 | Mkt Cap | 7.30B |
| Vol | 1.97M | Avg Vol | 19.99M | EPS | -0.10 | P/E | -327.30 | Forward P/E | 58.82 |
| Beta | 2.35 | Short Ratio | 3.27 | Inst. Own | 70.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 30.10 | 200-d Avg | 31.42 | 1yr Est | 28.42 |
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Li
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellne
B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 17.4% on an
Hims & Hers Health Inc (NYSE:HIMS) shares are rising on Wenesday after B of A Securities and Ca
HIMS facing negative impact on peptide optionality due to FDA's recommendation against adding 7
Canaccord Genuity analyst Maria Ripps maintains Hims & Hers Health (NYSE:HIMS) with a Buy and
B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
The Medicare GLP-1 Bridge program will be the first time eligible Medicare Part D patients will be a
Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 14.14% on an
As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today
Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance
These changes build on Caremark's industry leading efforts as a pharmacy benefits manager to exp
Benzinga examined the prospects for many investors' favorite stocks over the last week — here
Top Wall Street analysts updated their ratings on top companies. For full list of changes, including
Nasdaq 100 sinks as April CPI hits 3.8%; Sandisk, Micron and Intel each lose roughly 9% while the 30
Hims & Hers Health shares tank after disappointing Q1 results. Company raised 2026 revenue outlo
U.S. stock futures lower, Nasdaq down 200 points. AST SpaceMobile shares dip 11% after reporting wor
Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui
Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto
Top Wall Street analysts changed outlook on Adobe, AMD, Campbell's, Lineage, and WR Berkley. See
Analyst ratings for top stocks changed, including upgrades for FBP, CRWD, MSM.
Hims & Hers stock falls as Amazon launches a weight loss program with integrated care, pricing o
Nektar Therapeutics (NASDAQ: NKTR) rose on positive results for alopecia treatment. Other top gainer
A look at the most-searched tickers on Benzinga Pro for the month of March shows several newcomers a
Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro
Dow falls 200+ points as Serve Robotics Inc (NASDAQ: SERV) shares rise 16.2% on better-than-expected
Analysts change outlook on top names: Truist cut KFY price target, Oppenheimer raised AZO target, B.
US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer
Editor’s Note: The future prices of benchmark tracking ETFs and the headline were updated in the sto
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
Here's a look at the earnings calendar for the week ahead, including reports from Nvidia, Joby,
The complete list of Super Bowl 2026 commercials from Super Bowl LX and the companies behind the ads